Correction to: Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.

Chamberlain, Jayne L; Huda, Saif; Whittam, Daniel H; Matiello, Marcelo; Morgan, B Paul; Jacob, Anu

Chamberlain, Jayne L; Huda, Saif; Whittam, Daniel H; Matiello, Marcelo; Morgan, B Paul; Jacob, Anu.

Afiliação

Chamberlain JL; Ipsen Biopharm Ltd, 9 Ash Rd N, Wrexham, LL13 9UF, UK. drjlc1000@gmail.com.
Huda S; Department of Neurology, The Walton Centre, Lower Lane, Liverpool, L9 7LJ, UK.
Whittam DH; Department of Neurology, The Walton Centre, Lower Lane, Liverpool, L9 7LJ, UK.
Matiello M; Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
Morgan BP; School of Medicine, Henry Wellcome Building for Biomedical Research, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.
Jacob A; Department of Neurology, The Walton Centre, Lower Lane, Liverpool, L9 7LJ, UK.

J Neurol ; 268(5): 1665, 2021 May.

Article em En | MEDLINE | ID: mdl-31624952

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido